Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jeevan Scientific TechnologyBOM:538837 +1.17%65 Interest Coverage is 6.60 as of Mar. 2026, which is 382% above its 10-year median of 1.37. GuruFocus rates BOM:538837 with a GF Score™ of 65/100 and a GF Value™ of ₹61.75 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 376 Biotechnology companies, Jeevan Scientific Technology ranks worse than 93.09% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Jeevan Scientific Technology's
Operating Income
for the
three
months ended in Mar. 2026 was ₹26.9 Mil. Jeevan Scientific Technology's Interest Expense for the
three
months ended in Mar. 2026 was ₹-4.1 Mil.
Jeevan Scientific Technology's interest coverage for the quarter that ended in Mar. 2026 was 6.60.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Jeevan Scientific Technology's Interest Coverage or its related term are showing as below:
BOM:538837'
s Interest Coverage Range Over the Past 10 Years
Min: 0.66 Med: 1.37 Max: 15.16
Current: 1.56
BOM:538837's Interest Coverage is ranked worse than 93.09% of 376
companies
in the Biotechnology industry
Industry Median: 106.135
vs BOM:538837: 1.56
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Jeevan Scientific Technology Interest Coverage Related Terms
Jeevan Scientific Technology Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BOM:538837 vs VRTX, REGN, ALNY: Interest Coverage Comparison
For the Biotechnology subindustry, Jeevan Scientific Technology's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jeevan Scientific Technology Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jeevan Scientific Technology's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Jeevan Scientific Technology's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jeevan Scientific Technology (BOM:538837) has a Interest Coverage of 6.60 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Jeevan Scientific Technology and its competitors. This is 382% above median its historical median of 1.37. Over the past decade, Jeevan Scientific Technology's Interest Coverage has ranged from 0.66 to 15.16. According to the industry distribution chart, Jeevan Scientific Technology ranks #350 out of 376 companies in the Biotechnology industry, placing it in the top 93.1%.
Is Jeevan Scientific Technology's Interest Coverage too high?
Jeevan Scientific Technology's current Interest Coverage of 6.60 is 382% above median its 10-year median of 1.37. Over the past 10 years, this metric has ranged from a low of 0.66 to a high of 15.16. The Biotechnology industry median Interest Coverage is 106.14. Jeevan Scientific Technology's value of 6.60 is 93.8% below this industry median. Based on the distribution chart, Jeevan Scientific Technology ranks #350 out of 376 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Jeevan Scientific Technology has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jeevan Scientific Technology's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Jeevan Scientific Technology ranks #350 out of 376 companies for Interest Coverage. This places Jeevan Scientific Technology in the lower half of its industry. The industry median Interest Coverage is 106.14. Jeevan Scientific Technology's value of 6.60 is 93.8% below this benchmark. Historically, Jeevan Scientific Technology's own Interest Coverage has ranged from 0.66 to 15.16 over the past decade. While the company's 10-year median is 1.37 vs. the industry median of 106.14, Jeevan Scientific Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.14, based on 376 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jeevan Scientific Technology's current Interest Coverage of 6.60 is 93.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Jeevan Scientific Technology and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jeevan Scientific Technology's current Interest Coverage is 6.60, which is 382% above median its own 10-year median of 1.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeevan Scientific Technology stock overvalued right now?
Based on GuruFocus' analysis, Jeevan Scientific Technology (BOM:538837) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹61.75, compared to a current price of ₹72.77 — trading 17.8% above its estimated fair value. The current Interest Coverage is 6.60, which is 382% above median its 10-year median of 1.37 and 93.8% below the Biotechnology industry median of 106.14. Jeevan Scientific Technology's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Jeevan Scientific Technology (BOM:538837), the current Interest Coverage is 6.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jeevan Scientific Technology (BOM:538837) Overvalued in 2026?
Based on GuruFocus' analysis, Jeevan Scientific Technology stock appears to be overvalued.
The current stock price of ₹72.77 is trading 17.8% above its estimated GF Value™ of ₹61.75.
GuruFocus considers Jeevan Scientific Technology to be Modestly Overvalued.
Key valuation signals for BOM:538837:
Interest Coverage: 6.60 (382% above median its 10-year median of 1.37)
GF Value™: ₹61.75 vs. price of ₹72.77 (17.8% above fair value)
Industry Position: 93.8% below the Biotechnology median (#350 of 376)
No single metric tells the full story. See the BOM:538837 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jeevan Scientific Technology Ltd is an India-based company engaged in providing clinical research and data management services. Jeevan Scientific is an independent clinical contract research organization, offering reliable, cost-effective, and technology-driven clinical research solutions to various clients across the globe. Its services offer high-value testing services, including bioanalytical services for small and large molecules, ranging across generics, biosimilars, and other new drugs. It operates in a single segment, namely clinical research services.
65GF Score
Get the complete analysis for BOM:538837
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:538837 has been successfully added to your 
